Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Assertio Holdings Total Liabilities and Share Holders Equity 2010-2025 | ASRT

Assertio Holdings total liabilities and share holders equity from 2010 to 2025. Total liabilities and share holders equity can be defined as the total of all liabilities and shareholders' equity.
  
Assertio Holdings Annual Total Liabilities and Share Holders Equity
(Millions of US $)
2024 $285
2023 $286
2022 $414
2021 $327
2020 $303
2019 $527
2018 $933
2017 $1,039
2016 $1,225
2015 $1,357
2014 $711
2013 $509
2012 $142
2011 $164
2010 $87
2009 $92
Assertio Holdings Quarterly Total Liabilities and Share Holders Equity
(Millions of US $)
2025-03-31 $286
2024-12-31 $285
2024-09-30 $276
2024-06-30 $279
2024-03-31 $282
2023-12-31 $286
2023-09-30 $380
2023-06-30 $405
2023-03-31 $414
2022-12-31 $414
2022-09-30 $323
2022-06-30 $322
2022-03-31 $339
2021-12-31 $327
2021-09-30 $299
2021-06-30 $312
2021-03-31 $325
2020-12-31 $303
2020-09-30 $333
2020-06-30 $346
2020-03-31 $219
2019-12-31 $527
2019-09-30 $757
2019-06-30 $813
2019-03-31 $883
2018-12-31 $933
2018-09-30 $984
2018-06-30 $912
2018-03-31 $1,002
2017-12-31 $1,039
2017-09-30 $1,060
2017-06-30 $1,086
2017-03-31 $1,180
2016-12-31 $1,225
2016-09-30 $1,250
2016-06-30 $1,246
2016-03-31 $1,336
2015-12-31 $1,357
2015-09-30 $1,363
2015-06-30 $1,323
2015-03-31 $704
2014-12-31 $711
2014-09-30 $742
2014-06-30 $458
2014-03-31 $469
2013-12-31 $509
2013-09-30 $157
2013-06-30 $134
2013-03-31 $135
2012-12-31 $142
2012-09-30 $145
2012-06-30 $143
2012-03-31 $152
2011-12-31 $164
2011-09-30 $172
2011-06-30 $181
2011-03-31 $181
2010-12-31 $87
2010-09-30 $89
2010-06-30 $85
2010-03-31 $84
2009-12-31 $92
2009-09-30 $98
2009-06-30 $94
2009-03-31 $105
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.062B $0.125B
Assertio Holdings Inc. is a specialty pharmaceutical company. Its portfolio consists of branded prescription neurology, inflammation and pain medications. The company's business development includes acquisitions, licensing and mergers. Assertio Holdings Inc., formerly known as Assertio Therapeutics Inc., is based in LAKE FOREST, Ill.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $86.719B 32.53
Zoetis (ZTS) United States $69.528B 25.94
Takeda Pharmaceutical (TAK) Japan $48.047B 9.56
Daiichi Sankyo, - (DSNKY) Japan $43.343B 22.21
BeOne Medicines - (ONC) Cayman Islands $26.436B 0.00
Sandoz Group AG (SDZNY) Switzerland $23.802B 0.00
Merck (MKKGY) Germany $17.015B 12.47
Summit Therapeutics (SMMT) United States $15.299B 0.00
Shionogi (SGIOY) Japan $14.887B 0.00
United Therapeutics (UTHR) United States $12.822B 11.34
Neurocrine Biosciences (NBIX) United States $12.412B 42.51
Orion OYJ (ORINY) Finland $10.495B 28.38
IPSEN (IPSEY) France $9.739B 0.00
Corcept Therapeutics (CORT) United States $7.765B 63.12
Stevanato Group S.p.A (STVN) Italy $7.462B 45.63
Madrigal Pharmaceuticals (MDGL) United States $6.678B 0.00
Ionis Pharmaceuticals (IONS) United States $6.335B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.153B 0.00
Grifols, S.A (GRFS) Spain $6.092B 0.00
Ono Pharmaceutical (OPHLF) Japan $4.382B 13.33
Soleno Therapeutics (SLNO) United States $4.195B 0.00
Hypermarcas (HYPMY) Brazil $3.072B 20.21
Crinetics Pharmaceuticals (CRNX) United States $2.805B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.657B 9.31
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.548B 13.78
NewAmsterdam Pharma (NAMS) Netherlands $2.085B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.959B 0.00
Indivior (INDV) United States $1.923B 8.16
ARS Pharmaceuticals (SPRY) United States $1.787B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.754B 0.00
Endo (NDOI) United States $1.603B 0.00
Evotec AG (EVO) Germany $1.477B 0.00
Ocular Therapeutix (OCUL) United States $1.469B 0.00
Guardian Pharmacy Services (GRDN) United States $1.353B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.167B 23.35
Harrow (HROW) United States $1.133B 0.00
Dyne Therapeutics (DYN) United States $1.088B 0.00
Enliven Therapeutics (ELVN) United States $1.015B 0.00
Verve Therapeutics (VERV) United States $1.007B 0.00
Collegium Pharmaceutical (COLL) United States $0.962B 5.19
Akebia Therapeutics (AKBA) United States $0.959B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.890B 0.00
Ardelyx (ARDX) United States $0.883B 0.00
Elite Pharmaceuticals (ELTP) United States $0.760B 0.00
Xeris Biopharma Holdings (XERS) United States $0.735B 0.00
Cronos Group (CRON) Canada $0.733B 0.00
USANA Health Sciences (USNA) United States $0.580B 12.60
Xencor (XNCR) United States $0.579B 0.00
KalVista Pharmaceuticals (KALV) United States $0.567B 0.00
Relay Therapeutics (RLAY) United States $0.566B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.564B 0.00
Theravance Biopharma (TBPH) United States $0.561B 0.00
Bioventus (BVS) United States $0.556B 14.10
Zevra Therapeutics (ZVRA) United States $0.492B 0.00
AleAnna (ANNA) United States $0.481B 0.00
Organogenesis (ORGO) United States $0.466B 0.00
Siga Technologies (SIGA) United States $0.462B 9.64
Tourmaline Bio (TRML) United States $0.425B 0.00
Oruka Therapeutics (ORKA) United States $0.415B 0.00
Savara (SVRA) United States $0.382B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.348B 9.41
Heron Therapeutics (HRTX) United States $0.326B 0.00
Aquestive Therapeutics (AQST) United States $0.323B 0.00
Nektar Therapeutics (NKTR) United States $0.320B 0.00
Altimmune (ALT) United States $0.284B 0.00
Nature's Sunshine Products (NATR) United States $0.268B 24.58
Tonix Pharmaceuticals Holding (TNXP) United States $0.257B 0.00
Liminatus Pharma (LIMN) United States $0.247B 0.00
Aldeyra Therapeutics (ALDX) United States $0.227B 0.00
Nanobiotix S.A (NBTX) France $0.213B 0.00
MediWound (MDWD) Israel $0.208B 0.00
OmniAb (OABI) United States $0.208B 0.00
Esperion Therapeutics (ESPR) United States $0.197B 0.00
ProKidney (PROK) United States $0.196B 0.00
Larimar Therapeutics (LRMR) United States $0.194B 0.00
Profound Medical (PROF) Canada $0.180B 0.00
4D Molecular Therapeutics (FDMT) United States $0.178B 0.00
Journey Medical (DERM) United States $0.166B 0.00
Innate Pharma SA (IPHYF) France $0.163B 0.00
Aclaris Therapeutics (ACRS) United States $0.159B 0.00
Galectin Therapeutics (GALT) United States $0.147B 0.00
Avita Medical (RCEL) United States $0.144B 0.00
Lexeo Therapeutics (LXEO) United States $0.137B 0.00
Lyell Immunopharma (LYEL) United States $0.132B 0.00
Inhibikase Therapeutics (IKT) United States $0.120B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.118B 0.00
Cardiol Therapeutics (CRDL) Canada $0.117B 0.00
Korro Bio (KRRO) United States $0.113B 0.00
VAXART, INC (VXRT) United States $0.113B 0.00
Protara Therapeutics (TARA) United States $0.111B 0.00
Champions Oncology (CSBR) United States $0.107B 17.64
Corbus Pharmaceuticals Holdings (CRBP) United States $0.091B 0.00
Arch Biopartners (ACHFF) Canada $0.090B 0.00
Nutriband (NTRB) United States $0.089B 0.00
Unicycive Therapeutics (UNCY) United States $0.086B 0.00
Cassava Sciences (SAVA) United States $0.085B 0.00
Dominari Holdings (DOMH) United States $0.081B 0.00
Fractyl Health (GUTS) United States $0.080B 0.00
Vivani Medical (VANI) United States $0.078B 0.00
Achieve Life Sciences (ACHV) Canada $0.077B 0.00
Surrozen (SRZN) United States $0.077B 0.00
ESSA Pharma (EPIX) Canada $0.077B 0.00
Wellgistics Health (WGRX) United States $0.073B 0.00
Pyxis Oncology (PYXS) United States $0.068B 0.00
Context Therapeutics (CNTX) United States $0.059B 0.00
NRx Pharmaceuticals (NRXP) United States $0.059B 0.00
Gain Therapeutics (GANX) United States $0.059B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
Inotiv (NOTV) United States $0.058B 0.00
Rafael Holdings (RFL) United States $0.058B 0.00
PMV Pharmaceuticals (PMVP) United States $0.056B 0.00
Metagenomi (MGX) United States $0.055B 0.00
Avalo Therapeutics (AVTX) United States $0.052B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.048B 0.00
Telomir Pharmaceuticals (TELO) United States $0.046B 0.00
Century Therapeutics (IPSC) United States $0.045B 0.00
Prelude Therapeutics (PRLD) United States $0.044B 0.00
Mural Oncology (MURA) Ireland $0.043B 0.00
ElectroCore (ECOR) United States $0.040B 0.00
Iterum Therapeutics (ITRM) Ireland $0.040B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.039B 28.89
Karyopharm Therapeutics (KPTI) United States $0.038B 0.00
Acrivon Therapeutics (ACRV) United States $0.038B 0.00
PolyPid (PYPD) Israel $0.036B 0.00
Jupiter Neurosciences (JUNS) United States $0.035B 0.00
Enlivex Therapeutics (ENLV) Israel $0.028B 0.00
China SXT Pharmaceuticals (SXTC) China $0.027B 0.00
SCYNEXIS (SCYX) United States $0.027B 0.00
Tempest Therapeutics (TPST) United States $0.025B 0.00
Klotho Neurosciences (KLTO) United States $0.023B 0.00
VYNE Therapeutics (VYNE) United States $0.022B 0.00
FibroGen (FGEN) United States $0.021B 0.00
Relmada Therapeutics (RLMD) United States $0.020B 0.00
Natural Alternatives (NAII) United States $0.020B 0.00
DURECT (DRRX) United States $0.019B 0.00
Vivos Therapeutics (VVOS) United States $0.019B 0.00
BioLineRx (BLRX) Israel $0.019B 0.00
BioVie (BIVI) United States $0.019B 0.00
Lipocine (LPCN) United States $0.018B 0.00
Mannatech (MTEX) United States $0.017B 0.00
Carisma Therapeutics (CARM) United States $0.017B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.017B 0.00
Citius Pharmaceuticals (CTXR) United States $0.016B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.016B 0.00
Plus Therapeutics (PSTV) United States $0.016B 0.00
ProPhase Labs (PRPH) United States $0.015B 0.00
CASI Pharmaceuticals (CASI) China $0.015B 0.00
Ernexa Therapeutics (ERNA) United States $0.014B 0.00
TherapeuticsMD (TXMD) United States $0.013B 0.00
Minerva Neurosciences (NERV) United States $0.012B 2.17
Cosmos Health (COSM) United States $0.012B 0.00
Scienture Holdings (SCNX) United States $0.012B 0.00
Lyra Therapeutics (LYRA) United States $0.012B 0.00
Ainos (AIMD) United States $0.010B 0.00
Phio Pharmaceuticals (PHIO) United States $0.010B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.010B 0.00
Talphera (TLPH) United States $0.010B 0.00
Addex Therapeutics (ADXN) Switzerland $0.010B 0.00
Mangoceuticals (MGRX) United States $0.009B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.009B 0.00
Alaunos Therapeutics (TCRT) United States $0.008B 0.00
Biomerica (BMRA) United States $0.008B 0.00
Traws Pharma (TRAW) United States $0.008B 0.00
Nuvilex (PMCB) United States $0.007B 0.00
Indaptus Therapeutics (INDP) United States $0.007B 0.00
TransCode Therapeutics (RNAZ) United States $0.007B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.006B 0.00
Incannex Healthcare (IXHL) Australia $0.006B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
Aptorum Group (APM) United Kingdom $0.005B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
SHINECO (SISI) China $0.004B 0.00
Redhill Biopharma (RDHL) Israel $0.004B 0.00
InMed Pharmaceuticals (INM) Canada $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
CERo Therapeutics Holdings (CERO) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
SciSparc (SPRC) Israel $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.003B 0.00
PainReform (PRFX) Israel $0.003B 0.00
Aditxt (ADTX) United States $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
Jaguar Animal Health (JAGX) United States $0.003B 0.00
Heatwurx (PCSA) United States $0.002B 0.00
Conduit Pharmaceuticals (CDT) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
MEI Pharma (MEIP) United States $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00